NS Pharma Appoints Donald Foy as Vice President, Commercial and Promotes Jennifer Tamberino to National Sales Director
Position
Sales Director
Company
NS Pharma
ParamusBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
NS Pharma announced a change of leadership within its Commercial division. Donald Foy, previously serving as national sales director, was appointed to the role of vice president, Commercial. Jennifer Tamberino, who was Regional Business Director, East, National Sales, was promoted to backfill Foy's former position as national sales director.
Quick answer
NS Pharma Appoints Donald Foy as Vice President, Commercial and Promotes Jennifer Tamberino to National Sales Director (November 26, 2024). NS Pharma is based in Paramus, New Jersey, United States.
- Who is the new Sales Director at NS Pharma?
- NS Pharma named Jennifer Tamberino Sales Director, announced November 26, 2024.
- What did NS Pharma announce on November 26, 2024?
- NS Pharma announced a change of leadership within its Commercial division. Donald Foy, previously serving as national sales director, was appointed to the role of vice president, Commercial.
- What does NS Pharma do?
- NS Pharma, Inc., is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. NS Pharma is a registered trademark of the Nippon Shinyaku group of companies.
- Where is NS Pharma based?
- NS Pharma is based in Paramus, New Jersey, United States.
- Which similar companies made leadership changes around the same time?
- BerGenBio ASA (November 20, 2024), TORL BioTherapeutics (December 2, 2024), Virpax Pharmaceuticals (November 20, 2024) and NRx Pharmaceuticals (November 18, 2024) also announced leadership changes within 45 days of NS Pharma.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- BerGenBio Appoints Olav Hellebø as CEO (November 20, 2024)
- TORL BioTherapeutics Appoints Aran Maree, MD, as Chief Medical Officer and Initiates Global Phase 2 Study of TORL-1-23 (December 2, 2024)
- Virpax Pharmaceuticals Appoints Usama Chaudhry as Chief Financial Officer (November 20, 2024)
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- Arecor Therapeutics PLC Appoints David Ellam as Interim Chief Financial Officer to Succeed Susan Lowther (November 18, 2024)
- Selvita Appoints Dr. Paul Overton as Chief Commercial Officer (December 10, 2024)
Who to call at NS Pharma, and when
A new leader at NS Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day NS Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NS Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NS Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NS Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NS Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.